Viewing StudyNCT00515697



Ignite Creation Date: 2024-05-05 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00515697
Status: COMPLETED
Last Update Posted: 2014-06-18
First Post: 2007-08-13

Brief Title: A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-11
Start Date Type: None
Primary Completion Date: 2011-05
Primary Completion Date Type: ACTUAL
Completion Date: 2011-05
Completion Date Type: ACTUAL
First Submit Date: 2007-08-13
First Submit QC Date: August 13 2007
Study First Post Date: 2007-08-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2014-06-18
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2010-07-29
Disp First Submit QC Date: July 29 2010
Disp First Post Date: 2010-08-02
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2014-05-16
Last Update Post Date: 2014-06-18
Last Update Post Date Type: ESTIMATED